COVID-19疫苗反应在未感染与已感染SARS-CoV-2的血液透析受者中受不同风险因素影响
研究纳入103例血液透析受者(75例未感染、28例已感染SARS-CoV-2)和106例健康对照,分析两剂BNT162b2 mRNA疫苗接种后的抗体和T细胞反应。未感染血液透析受者的中和与非中和抗体反应低于未感染健康对照,且与既往移植、免疫抑制治疗、皮质类固醇治疗、低白蛋白血症、高龄、高血压及乙肝疫苗接种无应答相关;已感染血液透析受者的疫苗反应与健康对照相似,与感染至接种间隔及既往移植相关,而与未感染组其他风险因素无关。
要点
- 未感染血液透析受者接种两剂BNT162b2后中和与非中和抗体反应低于未感染健康对照。
- 未感染血液透析受者低疫苗反应与既往移植、免疫抑制治疗、皮质类固醇治疗、低白蛋白血症、高龄、高血压及乙肝疫苗无应答相关。
- 已感染SARS-CoV-2的血液透析受者疫苗反应与健康对照相似,与感染至接种间隔及既往移植相关。
核心结论
- COVID-19疫苗反应在未感染与已感染SARS-CoV-2的血液透析受者中受不同风险因素影响。
研究设计与样本
- 研究对103例血液透析受者(75例未感染、28例已感染SARS-CoV-2)和106例健康对照(40例未感染、66例已感染)接种两剂BNT162b2 mRNA疫苗后的抗体和T细胞反应进行了综合分析。
- 通过单因素和多因素分析,在未感染和已感染SARS-CoV-2的血液透析受者中分析与较低体液和细胞免疫相关的临床风险因素。
主要发现
- 未感染血液透析受者对疫苗接种的中和非中和抗体反应低于未感染健康对照。
- 未感染血液透析受者较低的疫苗反应与既往移植、免疫抑制治疗、皮质类固醇治疗、低白蛋白血症、高龄、高血压及乙肝疫苗接种无应答相关。
- 已感染SARS-CoV-2的血液透析受者的疫苗反应与健康对照相似,且与感染至接种间隔及既往移植相关,而与未感染血液透析受者中其他与低疫苗反应相关的风险因素无关。
临床怎么用
- 作者认为这些观察对理解疫苗诱导免疫及管理该脆弱患者群体具有重要意义。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Clinical risk factors of deficient immune responses to COVID-19 mRNA vaccination in SARS-CoV-2 naive hemodialysis recipients (HDR) have already been identified. Clinical factors influencing hybrid immunity induced by SARS-CoV-2 infection and vaccination in HDR have not been reported. METHODS: A comprehensive analysis of antibody (Ab) and T cell responses to two doses of BNT162b2 mRNA vaccination was performed in 103 HDR, including 75 SARS-CoV-2 naive and 28 experienced patients, and in 106 healthy controls (HC) not undergoing HD, including 40 SARS-CoV-2 naive and 66 experienced subjects. Clinical risk factors associated with lower humoral and cellular immunity were analyzed in SARS-CoV-2 naive and experienced HDR by univariate and multivariate analyses. RESULTS: Naive HDR had lower neutralizing and non-neutralizing antibody responses to vaccination than naive HC; lower vaccine responses were correlated with previous transplantation, immunosuppressive treatment, corticosteroid treatment, hypoalbuminemia, older age, hypertension, and negative response to hepatitis B vaccination. In contrast, vaccine responses of SARS-CoV-2 experienced HDR were similar to those of HC and were correlated with time between infection and vaccination and with previous transplantation, but not with the other risk factors associated with lower vaccine responses in naive HDR. CONCLUSION: COVID-19 vaccine responses are influenced by distinct risk factors in SARS-CoV-2 naive and experienced HDR. These observations have important implications for the understanding of vaccine-induced immunity and for the management of this vulnerable patient population.
引用
- Gemander N, Kemlin D, Depickère S, et al. COVID-19 vaccine responses are influenced by distinct risk factors in naive and SARS-CoV-2 experienced hemodialysis recipients. Vaccine. 2024. PMID: 39608249. doi:10.1016/j.vaccine.2024.126544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。